+ regulatory T (T Reg ) cells prevent autoimmune disease, maintain immune homeostasis and modulate immune responses during infection. To accomplish these tasks, T Reg cell activity is precisely controlled, and this requires T Reg cells to alter their migratory, functional and homeostatic properties in response to specific cues in the immune environment. We review progress in understanding the diversity of T Reg cells, T Reg cell function in different anatomical and inflammatory settings, and the influence of the immune environment on T Reg cell activity. We also consider how these factors affect immune-mediated disease in the contexts of infection, autoimmunity, cancer and transplantation.
1
. This is best exemplified by the severe systemic autoimmunity and lymphoproliferative disease observed in T Reg cell-deficient mice and in humans carrying non-functional or hypomorphic alleles of the FOXP3 gene. The impaired function and/or homeostasis of T Reg cells has also been implicated in the development of several common autoimmune and inflammatory diseases, including type 1 diabetes, rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus [2] [3] [4] [5] . In addition to preventing autoimmunity, T Reg cells regulate immunity to infections of viral, bacterial or parasitic origin, and can also restrain immune responses directed towards tumours or transplanted tissue 6, 7 . Thus, T Reg cells must 'walk the line' , allowing protective antitumour and antipathogen immunity, but preventing inflammatory disease by restraining aberrant responses to self or to innocuous antigens.
To function properly, T Reg cells must modulate the activities of a wide variety of cellular components of both the innate and the adaptive immune systems, and this depends on their ability to come into physical proximity with their targets by migrating to specific tissues and microenvironments. Additionally, it is crucial that T Reg cells use appropriate immunomodulatory mechanisms that can effectively inhibit the targeted cell population. Recently, it has become clear that T Reg cells can be divided into several distinct subsets, with unique functional and homeostatic properties, that work in concert to maintain normal immune homeostasis 8 . In this Review, we summarize recent advances in our understanding of the relationship between T Reg cell trafficking and function in lymphoid and non-lymphoid tissues, T Reg cell specialization during different types of immune responses, and the impact of the cytokine milieu on the phenotype, function and stability of T Reg cells.
Widespread distribution of T Reg cells T Reg cells localize to lymphoid and non-lymphoid sites.
The cells and tissues of the immune system are anatomically organized to facilitate the cellular interactions that are required for the development, activation, function and regulation of diverse leukocyte populations 9 . The organization of the immune system is the result of tissueand microenvironment-specific lymphocyte homing, which in turn is mediated by lymphocyte expression of surface adhesion and chemoattractant receptors. Although T Reg cells were initially identified in the secondary lymphoid tissues of mice and the peripheral blood of humans, they express a dizzying array of adhesion molecules and chemoattractant receptors that are expected to target them to both lymphoid and non-lymphoid sites (TABLE 1) . Indeed, in addition to their constitutive presence in secondary lymphoid tissues, T Reg cells can be found in most non-lymphoid tissues, even in the absence of any overt inflammation 10 . Additionally, T Reg cells can be found in abundance within tumours, where they are thought to blunt effective tumour clearance 7 . In recent years, genetic studies have revealed the importance of several homing receptors for the appropriate tissue distribution and function of T Reg cells. For instance, expression of the αe integrin chain (also known as CD103) and the chemokine receptor CC-chemokine receptor 4 (CCR4), as well as the ability to generate carbohydrate ligands for P-selectin and e-selectin by the action of the α-(1,3)-fucosyltransferase vII enzyme are all important for the migration and/or retention of T Reg cells within the skin. Accordingly, deletion of any of these molecules on T Reg cells results in the development of skin-specific auto immunity and altered pathogen clearance during cutaneous infection [10] [11] [12] [13] . similarly, loss of CCR7 blocks T Reg cell migration to the lymph nodes and inhibits T Reg cell function in an experimental model of colitis 14 . In addition to their constitutive recirculation, T Reg cell recruitment to non-lymphoid tissues is substantially enhanced during inflammation. However, the contributions of individual homing receptors to this 'inflammation-induced' T reg cell migration vary considerably depending on the tissue involved and the type of inflammatory response. For example, interleukin-17 (Il-17) produced during T helper 17 (T H 17) cellmediated inflammation promotes epithelial cell expression of the CCR6 ligand, CC-chemokine ligand 20 (CCl20), and CCR6 is essential for the optimal recruitment of T Reg cells to sites of T H 17-mediated inflammation in experimental autoimmune encephalomyelitis (eAe) 15 . similarly, interferon-γ (IFnγ) induces expression of the CXC-chemokine receptor 3 (CXCR3) ligands CXC-chemokine ligand 9 (CXCl9), CXCl10 and CXCl11 and the subsequent recruitment of CXCR3 + T Reg cells to the liver in a model of concanavalin A-induced hepatitis 16 . Additionally, CXCR3 may influence the microenvironmental positioning of T Reg cells in the central nervous system in eAe 17 . In this manner, recruitment of CCR6 + and CXCR3 + T Reg cells occurs downstream of the key effector cytokines Il-17 and IFnγ in a feedback loop to limit T H 17 cell-induced and T H 1 cell-induced inflammatory responses. • Association with tumour-infiltrating T Reg cells 129, 130 CCR, CC-chemokine receptor; CXCR, CXC-chemokine receptor; IL-10, interleukin-10; NOD, non-obese diabetic; SCID, severe combined immunodeficiency; T H , T helper; T Reg , regulatory T.
In addition to CCR6 and CXCR3, many other homing receptors have been implicated in the inflammatory recruitment of T Reg cells in different immunological settings, including CCR1, CCR2, CCR4, CCR5, CCR8, CCR9, CXCR4, CXCR5, CXCR6, α4β1 integrin (also known as vlA4), αeβ7 integrin, α4β7 integrin and the P-and e-selectin ligands. Indeed, T Reg cells probably use a combination of homing molecules that can function redundantly to control their migration during inflammatory responses. For example, in an islet allograft model, T Reg cells used CCR2, CCR5, CCR4 and P-and e-selectin ligands to migrate to the transplant site, whereas CCR2, CCR5 and CCR7 were required for trafficking from the inflamed allograft to the draining lymph node 18 . Interestingly, this sequential migration of T Reg cells from the graft site to the draining lymph node was required for prevention of graft rejection, highlighting the complex and dynamic nature of T Reg cell migration during inflammation. Thus, therapeutically targeting T Reg cell migration in the contexts of autoimmunity, transplantation, chronic infection and cancer remains a daunting task that will require significantly more study in both animal models and patient populations. 21 . This suggests that there is a 'division of labour' between distinct T Reg cell subsets that are specialized for functioning either in lymphoid or in nonlymphoid tissues. In addition, the phenotype of the CD44 hi effector-or memory-like T Reg cell pool indicates that this population arises as a result of T Reg cell activation, presumably owing to recognition of self-antigens in secondary lymphoid tissues
Differences in T Reg cells in lymphoid versus
.
Although the functional mechanisms used by T Reg cells are complex and still incompletely understood, there is increasing evidence that T Reg cells use different mechanisms to regulate immune responses in lymphoid and non-lymphoid tissues. This concept is best exemplified by the distinct phenotypes in mice that selectively lack T Reg cell expression of either Il-10 or cytotoxic T lymphocyte antigen 4 (CTlA4) (FIG. 1) 27, 28 . Together, these activities can raise the threshold required for T cell activation, thereby preventing the priming of autoreactive T cells. Indeed, time-lapse imaging studies have revealed that T Reg cells form long-lasting, stable contacts with DCs, and this has led to the hypothesis that a primary mode of T Reg cell-mediated suppression within lymphoid tissues may be through inhibition of DC activation and/or function 29, 30 . T Reg cells can also induce perforin-dependent cytolysis of DCs in tumour-draining lymph nodes 31 . Thus, T Reg cells use multiple mechanisms to limit DC activity in secondary lymphoid tissues, thereby quelling effector T cell activation and promoting functional tolerance. Accordingly, acute depletion of T Reg cells in mice leads to the rapid development of systemic autoimmunity, associated with increases in both the number and activation state of DCs in lymphoid tissues However, the identities of the natural self-antigens that are thought to drive T Reg cell development are still completely unknown. Despite the fact that T Reg cell specificity is still poorly characterized, there is evidence that T cell receptor (TCR) recognition has a key role in influencing the phenotype, function and localization of T Reg cells in vivo. For example, antigen-specific activation of T Reg cells isolated from TCR-transgenic mice alters their expression of several lymphocyte homing receptors, resulting in their subsequent redistribution to non-lymphoid tissues 10, 19 . Moreover, T Reg cells isolated from different tissues have distinct TCR repertoires, indicating that TCR-driven activation helps to impart cells with a tropism for specific sets of lymphoid and non-lymphoid tissues 107 . This probably occurs because T Reg cells specific for tissue-restricted self-antigens encounter signals during their activation that drive expression of tissue-specific homing receptors 62 . Although together these data suggest a key role for TCR recognition of specific self-antigens in driving the phenotypical diversity that is present among T Reg cells, a better understanding of the self-antigens recognized by T Reg cells is necessary to clarify precisely how their specificity affects their localization, phenotype, homeostasis and function. β simplex virus 2 (Hsv-2) accentuated T cell priming and proliferation in the draining lymph node, but prevented effector T cell mobilization from the lymph node to the vaginal epithelium, resulting in uncontrolled viral replication and death. These results highlight a previously unappreciated function of T Reg cells in down-modulating immune responses in the lymphoid tissues to allow efficient effector T cell migration to sites of infection 33 . The spontaneous phenotypes of mice lacking either Il-10 or CTlA-4 in T Reg cells demonstrate that these molecules are essential for proper T Reg cell function in vivo. However, numerous other mechanisms have been implicated in T Reg cell function in both lymphoid and non-lymphoid tissues in various experimental settings 34 . These include production of additional immuno suppressive cytokines such as transforming growth factor-β (TGFβ) and Il-35, along with metabolic inhibition of effector T cells through adenosine or cyclic AmP. Thus, T Reg cells use a variety of immunosuppressive mechanisms to modulate both the initiation of the immune response in secondary lymphoid tissues and the progression and termination of inflammatory responses at non-lymphoid sites, and the choice of mechanism seems to be influenced by both the tissue site and the character of the inflammatory response. Indeed, it has been difficult to determine the importance of specific T Reg cell immunoregulatory mechanisms, indicating that although T Reg cells are clearly essential for establishing and maintaining tolerance, substantial functional redundancy may exist in the means that they use to do so. Further unravelling of the complex relationship between T Reg cell localization and function is likely to yield important new insights into the functional diversity of T Reg cells and increase our understanding of how specific immunomodulatory functions are delivered to different tissues during the course of the immune response. 
T Reg cell control of distinct immune responses Functional specialization of T Reg cells. CD4
+ effector T cells can adopt one of several functional fates and elaborate distinct effector mechanisms depending on the cytokines that are present during their initial activation 35 . Production of these polarizing cytokines is dictated by the type of pathogen encountered, such that: TGFβ and Il-6 direct the development of Il-17-producing T H 17 cells during extracellular bacterial or fungal infection; IFnγ and Il-12 drive the differentiation of IFnγ-producing T H 1 cells that help to combat intracellular pathogens; and Il-4 induces Il-4-producing T H 2 cells during infection with large mucosal parasites [36] [37] [38] . The functional specialization of these various CD4 + T cell subsets is due to the differential expression of 'master' transcription factors, namely retinoic acid receptorrelated orphan receptor-γt (RORγt), T-bet and GATAbinding protein 3 (GATA3), which turn on distinct programmes of gene expression that control T cell function and migration [39] [40] [41] . However, each of these responses is pro-inflammatory and potentially harmful to host tissues. Accordingly, aberrant T H 1, T H 2 and T H 17 cell responses can all contribute to immunopathology in the contexts of infection, autoimmunity, allergy and other inflammatory conditions 42, 43 . Therefore, these distinct immune responses must be carefully regulated to ensure that they are initiated only when appropriate, and are efficiently resolved upon pathogen eradication or when the burden of tissue destruction outweighs the benefit of pathogen control. Indeed, defects in T Reg cell function can result in T H 1, T H 2 or T H 17 cell-mediated inflammatory disease, indicating that these cells are required for the proper regulation of multiple types of immune responses.
Recently, several groups demonstrated that T Reg cells use canonical T H cell-associated transcription factors to maintain or restore immune homeostasis during polarized T H 1, T H 2 and T H 17 cell-driven immune responses. T-bet is the master transcription factor controlling the differentiation, migration and function of IFnγ-producing T H 1 cells. In addition, T-bet influences the generation of effector and memory CD8 + T cells, and regulates the homeostasis and function of natural killer (nK) cells, thereby coordinating the cellular immune response to intracellular infection 40, [44] [45] [46] . Interestingly, T-bet is also expressed by a subset of T Reg cells, and is required for T Reg cell homeostasis and function during polarized T H 1-type inflammatory responses 47 . T-bet + T Reg cells accumulate at sites of T H 1-type inflammation, and T-bet-deficient T Reg cells display impaired proliferation during T H 1 cell-mediated immune responses, ultimately failing to control expansion of IFnγ-producing T H 1 cells when transferred into FOXP3-deficient scurfy mice.
similarly, T Reg cell expression of interferon regulatory factor 4 (IRF4), a transcription factor involved in the control of Il-4 production by CD4
+ T cells and in T H 2 cell differentiation, is required for T Reg cell-mediated control of T H 2-type inflammatory responses 48 . mice in which Irf4 is specifically deleted within FOXP3 + T Reg cells develop a lymphoproliferative disease that is associated with a selective increase in the number and frequency of Il-4-and Il-5-producing CD4 + T cells, and have elevated serum levels of IgG1 and Ige. Consistent with this increase in serum antibodies, these animals also contain dramatically increased numbers of plasma cells and spontaneously develop splenic germinal centres. Interestingly, IRF4 is also crucial for the differentiation of T follicular helper (T FH ) cells, which provide assistance to b cells and help to regulate antibody production in vivo 49 . The profound increase in germinal centre formation in mice with a T Reg cell-specific Irf4 deletion, in the absence of an increase in Il-13-producing CD4 + T cell or eosinophil numbers, indicates that T Reg cell expression of IRF4 may be required to control a specific component of T H 2 cell-associated inflammation, namely aberrant T FH cell activation and high-affinity antibody production.
Finally, deletion of signal transducer and activator of transcription 3 (Stat3) in T Reg cells results in the development of spontaneous fatal intestinal inflammation that is characterized by excessive Il-17 production but normal levels of T H 1 or T H 2 cell-associated inflammatory cytokines, indicating that there is selective dysregulation of T H 17-type responses in the absence of sTAT3-expressing T Reg cells 50 . The mechanisms by which T-bet, IRF4 and sTAT3 control T Reg cell activity during T H 1, T H 2 and T H 17 cell-mediated responses are still unclear, but are likely to involve a combination of influences on T Reg cell migration, function and homeostasis. For example, T Reg cells that are deficient in T-bet, IRF4 or sTAT3 display impaired expression of chemokine receptors that are implicated in T Reg cell localization during T H 1-, T H 2-or T H 17-type inflammation (CXCR3, CCR8 and CCR6, respectively), suggesting that altered T Reg cell migration may underlie some of the functional defects in these cells 47, 48, 50 . Additionally, loss of these transcription factors may affect the functional properties of T Reg cells. Of note, T Reg cells lacking T-bet, IRF4 or sTAT3 all show reduced expression of Il10 (REFs 47, 48, 50) . moreover, IRF4-deficient or sTAT3-deficient T Reg cells have reduced expression of other genes that are associated with T Reg cell function, such as Icos (inducible T cell co-stimulator), Fgl2 (fibrinogen-like protein 2), Ebi3 (epstein-barr virus-induced gene 3; which encodes a component of the immunosuppressive cytokine Il-35), Prf1 (perforin 1) and Gzmb (granzyme b) 48, 50 . by contrast, expression of Ctla4 is substantially increased in sTAT3-deficient T Reg cells, whereas Tgfb1 expression was unaltered in T Reg cells lacking any of the aforementioned transcription factors. Finally, loss of T-bet expression resulted in the impaired proliferation and accumulation of T Reg cells during T H 1-type inflammatory responses. Therefore, the failure of T-bet-deficient T Reg cells to control T H 1-driven inflammatory responses may result from their inability to survive and proliferate in a highly polarized T H 1-type environment 47 . From these data, a model emerges in which selective expression or activation of transcriptional regulators associated with T H 1, T H 2 and T H 17 cells drives the phenotypical and functional specialization of T Reg cells, endowing them with the molecular machinery needed to restrain these different types of CD4 + T cell responses (FIG. 2) . This model has important implications for the Thus, it will be crucial in future studies to identify and characterize the cellular and molecular mechanisms that underlie the functional specialization of T Reg cells, and to develop methods for selectively isolating and expanding different T Reg cell subsets.
Environmental control of T Reg cells
The need to carefully modulate both the number and the activity of T Reg cells to maintain the balance between autoimmunity and immunosuppression suggests that T Reg cells pay close attention to the immune environment and alter their phenotype, migration and function in response to specific cues that they encounter in the periphery. Cytokines are a diverse group of mainly secreted proteins that control nearly all aspects of leukocyte biology. They do so by binding to specific receptors on the surface of cells, and these receptors transmit signals promoting cellular proliferation, activation, differentiation and/or death. broadly speaking, cytokines can be divided into those that are constitutively expressed and promote normal lymphocyte development and homeo stasis, and those that are induced by specific inflammatory stimuli. Decades of research have demonstrated that both homeostatic and inflammatory cytokines have a profound influence on the phenotypical and functional differentiation of the various T cell populations. In addition to cytokines, small nonprotein molecules such as steroids, sphingo lipids and metab olites of vitamins A and D can also influence T cell differentiation, migration and function [51] [52] [53] [54] . In the following sections, we discuss recent progress in understanding how T Reg cells respond to the cytokines, vitamin metabolites and other factors that are present in the immune environment, and how this controls their activity in health and disease (FIG. 3) .
Control of T Reg cell homeostasis
Common-γ-chain-signalling cytokines. by far the best studied cytokine in terms of its impact on the development, homeostasis and function of T Reg cells is Il-2 (REF. 55 ). Indeed, T Reg cells were initially identified based on their constitutive expression of the high-affinity Il-2 receptor component CD25. moreover, it is clear that Il-2 has an essential and non-redundant role in controlling T Reg cell function in the periphery, as shown by the development of lymphoproliferative disease and colitis in mice that are deficient in either Il-2 or CD25. However, the precise manner by which Il-2 influences T Reg cell function is still largely unknown. several studies have demonstrated that T Reg cells occupy a distinct homeostatic 'niche' , and this is thought to be controlled in part by access to Il-2 (REFs 56,57). Accordingly, blocking Il-2 activity in mice through the administration of Il-2-specific antibodies decreases the proliferation of CD4 + CD25 + T cells and impairs T Reg cell function 58 . These data have led to a model in which Il-2 produced by activated CD4 + FOXP3 -T cells acts in a paracrine manner to promote T Reg cell proliferation and survival. However, both the frequency and the absolute number of peripheral T Reg cells are largely normal in mice lacking either Il-2 or CD25, indicating that the homeostasis of T Reg cells is more complicated than previously appreciated 59, 60 . Although the activated phenotype of T Reg cells in these mice is thought to be secondary to their inflammatory disease, an alternative interpretation of these results is that the crucial function of Il-2 is to help sustain the CD44 low CD25 hi T Reg cell subset, and that this population has a nonredundant function in preventing lymphoproliferative and autoimmune disease. The abundance of functional CD44 hi T Reg cells in Il-2-or CD25-deficient mice indicates that either the maintenance of these cells does not normally depend on Il-2, or other cytokines can compensate for loss of Il-2 in driving the homeostasis of this population. both Il-2 and Il-15 use the common γ-chain (also known as CD132) and CD122 as the signalling components of their receptors. As such, these two cytokines are thought to deliver very similar signals into cells, and [63] [64] [65] [66] . Among DCs, the enzymes that convert vitamin A into retinoic acid are most prominently expressed in a population of CD103 + DCs that is found in the intestine and the gut-associated lymphoid tissues 64, 65 . Thus, under steadystate conditions, retinoic acid produced by these DCs is thought to influence the balance of effector and regulatory T cells in the intestine, and help promote tolerance to commensal bacteria and food antigens.
Although retinoic acid is primarily thought to promote T Reg cell activity in the intestine, the active form of vitamin D (1,25-dihydroxyvitamin D3) can have similar effects in the skin, where vitamin D is produced in response to sunlight. 1,25-dihydroxyvitamin D3 can both augment the function of existing T Reg cells and promote de novo differentiation of T Reg cells from naive CD4 + T cell precursors, in a similar way to retinoic acid 54, 67 . moreover, 1,25-dihydroxyvitamin D3 produced by cutaneous DCs can induce T cell expression of CCR10, a chemokine receptor that is implicated in T cell localization to the epidermis 68 , although this has not been formally demonstrated in T Reg cells. nonetheless, these data raise the intriguing possibility that anatomical cues delivered by metabolites that are enriched in the skin or the intestine can drive T Reg cell specialization, endowing them with the migratory and functional properties needed for immunoregulation in these tissues.
Inflammatory cytokines and T Reg cells
During infection, cytokines that are produced in response to pathogen recognition by cells of the innate immune system initiate the inflammatory response, which is subsequently amplified by products of the adaptive immune response. These inflammatory cytokines have broad effects on the phenotypes, functions and migration of T cells and other leukocyte populations, and ultimately dictate the course of patho gen control. Additionally, dysregulated production of inflammatory cytokines underlies the pathogenesis of most autoimmune and inflammatory diseases. because of their central function in driving inflammatory responses, it is not surprising that many of these cytokines can also act directly on T Reg cells, influencing their phenotype and activity in complex ways such that vigorous immune responses are allowed to occur when necessary, but generally with the restraint needed to prevent collateral damage and immunopathology. Indeed, this complexity is only beginning to be appreciated and addressed experimentally, and although not exhaustive, the following discussion highlights the fact that many cytokines can have both positive and negative effects on T Reg cell activity. Thus, careful analyses are still required to determine how T Reg cell activity is augmented and inhibited by various inflammatory cytokines during different types of inflammatory responses. This promises to be a fruitful area of future study that will have considerable implications for the development of therapies aimed at manipulating T Reg cell activity.
IFNγ and IL-12.
IFnγ and Il-12 function together to promote T H 1 cell differentiation and function 69 . Additionally, IFnγ is the principal effector cytokine produced by T H 1 cells, nK cells and CD8 + T cells, and is required for clearance of intracellular pathogens such as Mycobacterium tuberculosis, Leishmania major and Listeria monocytogenes [70] [71] [72] . similar to many other inflammatory cytokines, IFnγ actively inhibits the peripheral generation of FOXP3 + T Reg cells from naive CD4 + cells 73 . However, IFnγ signalling through sTAT1 activation also drives T-bet expression by thymus-derived T Reg cells, and as discussed in the preceding section, this endows them with the molecular machinery that is required for the efficient control of T H 1-type responses 47 . Thus, in addition to being a pro-inflammatory cytokine essential for combating intracellular pathogens, IFnγ has an immuno regulatory function that may help to limit the magnitude and duration of T H 1-type inflammatory responses. However, although IFnγ-induced signalling within T Reg cells may be beneficial for the differentiation of functionally specialized T-bet + T Reg cells, excessive sTAT1 activation can have a deleterious effect on T Reg cell function, resulting in excessive T H 1 cell activity and inflammatory disease 74 . similarly, a recent study demonstrated that when Il-2 availability is limited during oral infection with Toxoplasma gondii, T Reg cells become Il-12 responsive, express high amounts of T-bet and acquire the ability to produce IFnγ, subsequently contributing to the fatal intestinal immunopathology that develops during infection 75 . Thus, IFnγ and Il-12 can either promote or inhibit T Reg cell activity depending on the magnitude of the cytokine response and the context in which it is perceived. These studies emphasize the need to precisely regulate T Reg cell responses to these cytokines during T H 1 cell-mediated inflammation, and underscore the complex and confounding impact that cytokines can have on T Reg cell activity in vivo.
IL-6.
Il-6 is a widely expressed cytokine with multiple functions that can have a profound influence on T Reg cell development and activity 76, 77 . For example, Il-6 potently prevents the TGFβ-mediated development of induced T Reg cells, and instead acts with TGFβ to induce T H 17 cell differentiation 78 . Thus, the presence or absence of Il-6 can regulate the induction of pro-inflammatory and tolerogenic T cell responses, respectively. moreover, in addition to controlling the development of induced T Reg cells, Il-6 can also influence the stability and function of thymus-derived T Reg cells. For example, stimulation of T Reg cells in the presence of Il-6 results in loss of FOXP3 expression and acquisition of a T H 17 cell phenotype and function 79, 80 . moreover, Il-6 produced downstream of
Box 2 | T Reg cell homeostasis -beyond IL-2
Lymphocyte homeostasis is the process by which various T and B cell populations are maintained at near constant frequencies in the periphery owing to their balanced generation, proliferation and death. The major cytokine thought to control regulatory T (T Reg ) cell homeostasis is interleukin-2 (IL-2). However, many other factors have been identified that influence T Reg cell homeostasis. For example, T Reg cell expression of the co-stimulatory molecule CD28 is required for their peripheral maintenance, and T Reg cell numbers are substantially reduced in CD28-deficient mice 108 . Accordingly, these animals show enhanced susceptibility to autoimmune diabetes 109 . Given that T Reg cells form long-lasting contacts with dendritic cells (DCs) in the secondary lymphoid tissues, it is also not surprising that T Reg cell proliferation and abundance are highly sensitive to changes in DC frequency 110 . This is probably due to the ability of DCs to present self-antigens to T Reg cells and to provide CD28-dependent co-stimulatory signals through CD80 and CD86 that can drive T Reg cell activation and proliferation. Another molecule that influences T Reg cell homeostasis is sphingosine-1-phosphate (S1P). S1P is best known for promoting lymphocyte egress from the thymus, spleen and lymph nodes. However, T Reg cells overexpressing the S1P receptor S1P 1 (also known as S1PR1) have a competitive disadvantage in the periphery, suggesting that S1P can also modulate the proliferation and/or survival of T Reg cells through activation of the AKT-mTOR (mammalian target of rapamycin) pathway 51 . Other molecules implicated in T Reg cell homeostasis include CD44, which can promote T Reg cell proliferation upon binding to high-molecular-mass hyaluronan in the extracellular matrix 111 , and CC-chemokine receptor 4 (CCR4), which is required for the proper homeostasis of CD103 hi cutaneous T Reg cells 10 . Thus, T Reg cell homeostasis is far more complex than currently appreciated, and much more work needs to be done to understand how T Reg cell abundance is controlled in various tissues, both in the steady state and during the course of different types of immune responses.
Toll-like receptor ligation blocks T Reg cell-mediated inhibition of T cell activation, and this is probably due both to direct effects of Il-6 on T Reg cells, and to the ability of Il-6 to render effector T cells resistant to T Reg cell-mediated suppression 81 . Although these studies emphasize the ability of Il-6 to inhibit T Reg cell activity, the importance of sTAT3 for T Reg cell-mediated control of T H 17 responses raises the intriguing question: what are the important sTAT3-activating cytokines that act on T Reg cells? Il-6 is a potent activator of sTAT3, and thus it is tempting to speculate that, as with IFnγ and sTAT1 during T H 1 cell responses, Il-6 simultaneously promotes T H 17 cell differentiation while acting on T Reg cells through sTAT3 to maximize their ability to modulate T H 17-type responses. However, several other cytokines also activate sTAT3, including Il-10, Il-27 and Il-21, and the impact of these cytokines on T Reg cell activity during T H 17-type responses remains to be determined. nonetheless, it is clear that the presence or absence of Il-6 can modulate T Reg cell activity during inflammatory responses. As drugs that target Il-6 reach the clinic 82 , it will be interesting to determine how Il-6 blockade affects the abundance, phenotype and functional activity of T Reg cells in the context of immunemediated diseases such as rheumatoid arthritis and inflammatory bowel disease.
IL-4.
Il-4 is a key effector cytokine produced by T H 2 cells, and is also required for T H 2 cell differentiation. However, although the effects of Il-4 on T H 2 cell differentiation and function are well characterized, its impact on T Reg cell stability and function are not well understood. Indeed, like many other inflammatory cytokines, Il-4 can both augment and inhibit T Reg cell development and function in different experimental settings. For instance, similar to Il-6, Il-4 can inhibit TGFβ-induced peripheral T Reg cell development and act with TGFβ to drive development of a recently described population of Il-9-producing effector T cells 83, 84 . Additionally, Il-4 is thought to render T H 2 cells resistant to T Reg cell-mediated suppression 85 . by contrast, Il-4 stimulation of T Reg cells can boost their expression of CD25 and FOXP3, prevent their apoptosis and increase their suppressive function in vitro 85, 86 . Thus, the effects of Il-4 on T Reg cells clearly require further investigation and probably depend on other factors, such as the presence or absence of TGFβ in the inflammatory environment.
Type 1 IFNs. The type 1 IFns are a group of more than a dozen closely related cytokines that are highly upregulated during viral infection. They function to block viral replication and to qualitatively and quantitatively influence the antiviral adaptive immune response. However, overproduction of type 1 IFns has been associated with a variety of autoimmune disorders 87 . surprisingly, despite the dramatic effects type 1 IFns can have on conventional CD4
+ and CD8 + effector T cells, and the clear association between type 1 IFn production and the development of autoimmunity, the effects of type 1 IFns on the development, homeostasis and function of T Reg cells are largely unexplored. several studies have indicated that IFnβ treatment can help to restore the number and function of T Reg cells in patients with multiple sclerosis 88, 89 . by contrast, stimulation with IFnα inhibited T Reg cell generation in an in vitro culture system, although this was largely due to inhibition of effector T cell production of Il-2 (REF. 90 ). Clearly, further defining how type 1 IFns affect T Reg cells will help delineate how T Reg cell activity is controlled during acute and chronic viral infections and in type 1 IFn-associated autoimmune diseases.
TNF and IL-1. Tumour necrosis factor (TnF) and Il-1 are both pleiotropic cytokines that act on a wide range of cells and generally promote inflammation. Indeed, both TnF and Il-1 have been successfully targeted therapeutically for the treatment of a number of inflammatory and autoimmune diseases, including rheumatoid arthritis, psoriasis and inflammatory bowel disease 91 . It is not surprising, therefore, that these cytokines can significantly affect T Reg cell function. Although TnF is primarily known for its pro-inflammatory functions, most current evidence indicates that upon binding and signalling through TnF receptor 2 (TnFR2; also known as TnFRsF1b) this cytokine actually potentiates T Reg cell activity 92 . Indeed, TnFR2 is expressed by a subset of effector or memory phenotype T Reg cells that are highly suppressive, and in vitro treatment of mouse T Reg cells with TnF can augment their proliferation and suppressive activity 93 . Furthermore, blockade of TnF actually exacerbates cutaneous inflammation in a mouse model of psoriasis, and this is associated with decreased frequency of T Reg cells 94 . similarly, TnF-TnFR2 interactions may control T Reg cell population expansion during cecal ligation and puncture (ClP) in mice 93 , although the requirement for direct recognition of TnF by T Reg cells was not addressed in either the psoriasis or ClP studies. To determine whether a portion of T Reg cells convert to an effector phenotype following transfer to lymphopenic mice, two groups recently generated mice that were engineered to track the fate of FOXP3 + cells in vivo. In these systems, mice expressing the Cre recombinase in T Reg cells under the control of regulatory elements from the Foxp3 gene were crossed with mice in which Cre-mediated recombination removes a stop codon from within a fluorescent-protein-encoding reporter gene that was knocked in to the ubiquitously expressed Rosa26 locus. Thus, in these animals, cells even transiently expressing FOXP3 are permanently marked, and their phenotypical and functional properties can be spatially and temporally examined. using this system, bluestone and colleagues observed that a portion of CD4 + FOXP3
+ T cells downregulate FOXP3 expression and acquire the ability to produce effector cytokines such as IFnγ, even in the absence of any experimental manipulation. Furthermore, the frequency of these 'ex-T Reg cells' was increased in the pancreatic islets of non-obese diabetic (nOD) mice, indicating that they may contribute to autoimmune pathology 101 . These data are complemented by another recent study demonstrating that during infection with Toxoplasma gondii, T Reg cells can lose FOXP3 expression and acquire T H 1 cell effector characteristics 75 . Together, these studies suggest that highly polarized inflammatory environments can subvert T Reg cell function by converting them to FOXP3 -effector T cells in vivo, and are consistent with a recent epigenetic analysis demonstrating that the loci encoding the key transcription factors and cytokines that are associated with T H 1, T H 2 and T H 17 cells are not fully repressed in T Reg cells 102 . However, using a similar reporter mouse system to monitor T Reg cell stability, Rudensky's group recently demonstrated that FOXP3 expression by T Reg cells is remarkably stable, even in highly inflammatory settings 103 . The discrepancies in these studies may be due to differences in the inflammatory systems used to examine T Reg cell stability in vivo, or to subtle differences in the way the reporter mice were constructed. bluestone's group drove Cre expression using a bacterial artificial chromosome (bAC) transgene, whereas Rudensky's group knocked a Cre expression cassette into the 3ʹ untranslated region of the endogenous Foxp3 locus. This may have led to differences in the timing and extent of Cre expression that resulted in the divergent conclusions of these studies.
In discussing the stability of T Reg cells, it is also important to keep in mind the differences in FOXP3 expression that have been observed in mouse and human T cells. In mice, FOXP3 seems to be a robust marker for thymicderived and induced T Reg cells. However, nearly all human CD4 + T cells transiently express FOXP3 during activation, and this is not associated with acquisition of regulatory function. Thus, FOXP3 alone is not a reliable marker for human T Reg cells, further complicating analyses of their function and stability. moreover, because thymic output is severely curtailed following puberty and fewer T Reg cells emerge from the thymus, the less-stable induced T Reg cells may assume a greater role in maintaining immune homeostasis in adults 104 . Clearly, the degree to which T Reg cells can acquire effector functions and contribute to the development of autoimmune and inflammatory diseases merits further study, and careful attention must be paid to the potential differences between mouse and human systems.
Concluding remarks
T Reg cells have emerged as potent anti-inflammatory cells, and this has generated considerable excitement because of the potential to therapeutically manipulate T Reg cell activity to treat autoimmune disease, prevent graft rejection, and boost immune responses during cancer and chronic infection 105 . However, it is now evident that T Reg cells are a dynamic and diverse T cell population composed of several phenotypically and functionally distinct subsets, the differentiation and function of which are controlled by specific signals in the immune environment. Thus, in order to optimally utilize T Reg cells in the clinic, it is essential that we better understand how these subsets function together to ensure that robust immune responses can occur when needed without the development of significant immunopathology and inflammatory disease. Key unresolved issues include: defining the importance of each T Reg cell subset in the control of different types of inflammatory responses; identifying the factors that govern the peripheral differentiation of these subsets; and determining how cytokines and other factors in the immune environment influence T Reg cell activity and stability during the initiation, progression and termination of normal and pathological immune responses. 
